Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease

Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease

SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its...

CGTN: Extraordinary Navigation: How China strides forward with confidence

CGTN: Extraordinary Navigation: How China strides forward with confidence

BEIJING, Jan. 3, 2026 /PRNewswire/ -- The Innovation-driven development is reshaping a dynamic and vibrant China. According to the World Intellectual Property Organization, the country, for the first time, entered into the top 10 list in the global...

GAC's Global Ecosystem Takes Shape as Overseas Sales Nearly Triple in Two Years

GAC's Global Ecosystem Takes Shape as Overseas Sales Nearly Triple in Two Years

GUANGZHOU, China, Jan. 1, 2026 /PRNewswire/ -- GAC released its 2025 overseas performance report, announcing exports of over 130,000 vehicles, a year‑on‑year increase of 45%. Over the past two years, GAC's international business has achieved...

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

SHANGHAI, Dec. 31, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks...

Leifras Notice regarding the conclusion of a commitment line agreement totaling 2.5 billion yen to diversify fund-raising channels and strengthen the financial base

Leifras Notice regarding the conclusion of a commitment line agreement totaling 2.5 billion yen to diversify fund-raising channels and strengthen the financial base

TOKYO, Dec. 25, 2025 /PRNewswire/ -- Leifras Co., Ltd. (NASDAQ: LFS, Head Office: Shibuya-ku, Tokyo, Representative Director: Kiyotaka Ito, hereinafter referred to as "the Company"), which operates sports schools for children and supports the local...

From Discoverative AI to the Entropy of Tolerance: Tianqiao Chen's Vision of Human-AI Co-Evolution

From Discoverative AI to the Entropy of Tolerance: Tianqiao Chen's Vision of Human-AI Co-Evolution

SAN MATEO, Calif., Dec. 24, 2025 /PRNewswire/ -- Shanda Group has entered a period of renewed visibility, with a series of incubated ventures coming to light over the past several months. At the center of this momentum is its founder, Tianqiao Chen,...

From Black Friday to Christmas: HEISR Turns Everyday Oral Care into a Gift That Lasts All Year

From Black Friday to Christmas: HEISR Turns Everyday Oral Care into a Gift That Lasts All Year

Why a Three-Sided Toothbrush Is Becoming One of the Most Thoughtful Holiday Gifts for Modern Families LAS VEGAS, Dec. 24, 2025 /PRNewswire/ -- During this year's Black Friday season, HEISR re-entered the spotlight in the U.S. market with its...

Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73

Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73

BEIJING, SHANGHAI and BOSTON, Dec. 21, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK,) today announced that it has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73. AstraZeneca will receive exclusive development...

RIMAN Makes Highly Anticipated Japan Debut with Bustling Launch Events

RIMAN Makes Highly Anticipated Japan Debut with Bustling Launch Events

SEOUL, South Korea, Dec. 18, 2025 /PRNewswire/ -- RIMAN, a premium Korean skincare and wellness brand, today announced it has officially entered the Japanese market with significant momentum from two successful launch events. The events took place...

Lady M Strengthens Global Strategy in Singapore, Deepening Commitment to Southeast Asia

Lady M Strengthens Global Strategy in Singapore, Deepening Commitment to Southeast Asia

NEW YORK, Dec. 17, 2025 /PRNewswire/ -- Lady M Confections Co., Ltd. ("Lady M"), the internationally renowned luxury patisserie brand, today reaffirmed the strategic importance of Singapore within its global growth plans and announced a transition...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • menu
    menu